Mark Esposito

Mark Esposito

Auto-generated profile, based on publicly available information

Mark Esposito

Department of Molecular Biology, Princeton University, Princeton, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Cell Metabolism
Verified
Journal Article
Closed access
GDGregory S. Ducker
Gregory S. Ducker
LCLi Chen
Li Chen
RMRaphael J. Morscher
Raphael J. Morscher
JGJonathan M. Ghergurovich
Jonathan M. Ghergurovich
MEMark Esposito
Mark Esposito
JRJoshua D. Rabinowitz
Joshua D. Rabinowitz

15 April 2019 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MEMark Esposito
Mark Esposito
NMNandini Mondal
Nandini Mondal
TGTodd M. Greco
Todd M. Greco
YWYong Wei
Yong Wei
CSChiara Spadazzi
Chiara Spadazzi
YKYibin Kang
Yibin Kang

1 January 2019 in Cancer Cell
Verified
Journal Article
Closed access
MSMinhong Shen
Minhong Shen
YJYi-Zhou Jiang
Yi-Zhou Jiang
YWYong Wei
Yong Wei
BEBrian Ell
Brian Ell
XSXinlei Sheng
Xinlei Sheng
YKYibin Kang
Yibin Kang

24 March 2021 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
MEMark Esposito
Mark Esposito
SGShridar Ganesan
Shridar Ganesan
YKYibin Kang
Yibin Kang

3 November 2017 in Cold Spring Harbor Perspectives in Medicine
Verified
Journal Article
Closed access
PDF file
MEMark Esposito
Mark Esposito
TGTheresa Guise
Theresa Guise
YKYibin Kang
Yibin Kang
Bone metastasis, or the development of secondary tumors within the bone of cancer patients, is a debilitating and incurable disease. Despite its morbidity, the biology of bone metastasis represents one of the most complex and intriguing of all oncogenic processes. This complexity derives from the intricately organized bone microenvironment in which the various stages of hematopoiesis, osteogenesis, and osteolysis are jointly regulated but spatially restricted. Disseminated tumor cells (DTCs) from various common malignancies such as breast, prostate, lung, and kidney cancers or myeloma are uniquely primed to subvert these endogenous bone stromal elements to grow into pathological osteolytic or osteoblastic lesions. This colonization process can be separated into three key steps: seeding, dormancy, and outgrowth. Targeting the processes of dormancy and initial outgrowth offers the most therapeutic promise. Here, we discuss the concepts of the bone metastasis niche, from controlling tumor-cell survival to growth into clinically detectable disease.

1 December 2017 in Cancer Cell
Verified
Journal Article
Closed access
HZHanqiu Zheng
Hanqiu Zheng
YBYangjin Bae
Yangjin Bae
SKSabine Kasimir-Bauer
Sabine Kasimir-Bauer
RTRebecca Tang
Rebecca Tang
JCJin Chen
Jin Chen
YKYibin Kang
Yibin Kang